- Home
- APLS vs NMRK Comparison
APLS vs NMRK Comparison
Compare APLS & NMRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- NMRK
- Stock Information
- Founded
- APLS 2009
- NMRK 1929
- Country
- APLS United States
- NMRK United States
- Employees
- APLS N/A
- NMRK N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- NMRK Real Estate
- Sector
- APLS Health Care
- NMRK Finance
- Exchange
- APLS Nasdaq
- NMRK Nasdaq
- Market Cap
- APLS 2.9B
- NMRK 3.4B
- IPO Year
- APLS 2017
- NMRK 2017
- Fundamental
- Price
- APLS $19.91
- NMRK $17.31
- Analyst Decision
- APLS Buy
- NMRK Strong Buy
- Analyst Count
- APLS 20
- NMRK 5
- Target Price
- APLS $33.15
- NMRK $19.00
- AVG Volume (30 Days)
- APLS 3.1M
- NMRK 1.2M
- Earning Date
- APLS 10-30-2025
- NMRK 10-30-2025
- Dividend Yield
- APLS N/A
- NMRK 0.70%
- EPS Growth
- APLS N/A
- NMRK 94.50
- EPS
- APLS 0.36
- NMRK 0.59
- Revenue
- APLS $1,016,397,000.00
- NMRK $3,160,782,000.00
- Revenue This Year
- APLS $25.39
- NMRK $19.70
- Revenue Next Year
- APLS N/A
- NMRK $9.58
- P/E Ratio
- APLS $55.70
- NMRK $29.20
- Revenue Growth
- APLS 42.11
- NMRK 20.95
- 52 Week Low
- APLS $16.10
- NMRK $9.65
- 52 Week High
- APLS $35.72
- NMRK $19.84
- Technical
- Relative Strength Index (RSI)
- APLS 33.72
- NMRK 37.63
- Support Level
- APLS $19.44
- NMRK $16.81
- Resistance Level
- APLS $30.48
- NMRK $19.84
- Average True Range (ATR)
- APLS 1.58
- NMRK 0.62
- MACD
- APLS -0.96
- NMRK -0.20
- Stochastic Oscillator
- APLS 5.17
- NMRK 14.21
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About NMRK Newmark Group Inc.
Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.